Amundi ETF MSCI Europe Healthcare UCITS ETF (CH5.L) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with CH5.L. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.
Cheapest Alternatives to CH5.L
CH5.L charges 0.25% annually. There are 10 ETFs in the Health & Biotech Equities category with lower expense ratios, going as low as 0.12%.
| Symbol | Name | Expense Ratio | AUM | Inception | |
|---|---|---|---|---|---|
| Xtrackers MSCI USA Health Care UCITS ETF 1D | 0.12% | 644.55M | Sep 2017 | CH5.L vs XSHC.L | |
| Invesco US Health Care Sector UCITS ETF | 0.14% | 343.20M | Dec 2009 | CH5.L vs XLVP.L | |
| Invesco Health Care S&P US Select Sector UCITS ETF... | 0.14% | 461.66M | Dec 2009 | CH5.L vs XLVS.L | |
| iShares S&P 500 Health Care Sector UCITS ETF USD (... | 0.15% | 2.55B | Jun 2020 | CH5.L vs IUHC.L | |
| SPDR S&P US Health Care Select Sector UCITS ETF | 0.15% | — | Jul 2015 | CH5.L vs GXLV.L |
Best Risk-Adjusted Alternatives to CH5.L
CH5.L has a PortfoliosLab risk / return rank of 17. There are 24 ETFs in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 76.
| Symbol | Name | Risk / Return Rank | AUM | Inception | |
|---|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF | 76 | 624.54M | Oct 2017 | CH5.L vs BTEK.L | |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dis... | 72 | 55.04M | Mar 2018 | CH5.L vs BTEE.L | |
| Invesco Nasdaq Biotech UCITS ETF | 72 | 407.93M | Nov 2014 | CH5.L vs SBIO.L | |
| Global X Genomics & Biotechnology UCITS ETF | 62 | 20.00M | Nov 2021 | CH5.L vs GNOG.L | |
| WisdomTree BioRevolution UCITS ETF USD Acc | 61 | 12.52M | Dec 2021 | CH5.L vs WBIO.L |
Top Performing CH5.L Alternatives (YTD)
CH5.L is at -3.01% YTD. There are 25 ETFs in the Health & Biotech Equities category with higher YTD returns, going as high as 12.27%.
| Symbol | Name | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|
| Global X Genomics & Biotechnology UCITS ETF | 12.27% | 20.00M | Nov 2021 | CH5.L vs GNOG.L | |
| WisdomTree BioRevolution UCITS ETF USD Acc | 10.42% | 12.52M | Dec 2021 | CH5.L vs WBIO.L | |
| First Trust NYSE Arca Biotechnology UCITS ETF Acc | 8.97% | 9.55M | May 2020 | CH5.L vs FBT.L | |
| iShares Nasdaq US Biotechnology UCITS ETF | 4.86% | 624.54M | Oct 2017 | CH5.L vs BTEK.L | |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dis... | 4.58% | 55.04M | Mar 2018 | CH5.L vs BTEE.L |
Lowest Volatility Alternatives to CH5.L
CH5.L has 16.28% 1-year volatility. There are 9 ETFs in the Health & Biotech Equities category with lower 1-year volatility, going as low as 13.70%.
| Symbol | Name | Volatility 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| SPDR MSCI World Health Care UCITS ETF | 13.70% | — | Apr 2016 | CH5.L vs HEAW.L | |
| Lyxor UCITS MSCI World Health Care TR C-USD | 14.52% | 913.84M | Aug 2010 | CH5.L vs HLTW.L | |
| Xtrackers MSCI World Health Care UCITS ETF 1C | 14.57% | 3.40B | Mar 2016 | CH5.L vs XDWH.L | |
| Xtrackers MSCI USA Health Care UCITS ETF 1D | 14.72% | 644.55M | Sep 2017 | CH5.L vs XSHC.L | |
| Invesco US Health Care Sector UCITS ETF | 14.76% | 343.20M | Dec 2009 | CH5.L vs XLVP.L |
Lowest Drawdown Alternatives to CH5.L
CH5.L has a 1-year max drawdown of -13.44%. There are 18 ETFs in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as -6.89%.
| Symbol | Name | Max Drawdown 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF | -6.89% | 624.54M | Oct 2017 | CH5.L vs BTEK.L | |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dis... | -7.63% | 55.04M | Mar 2018 | CH5.L vs BTEE.L | |
| Invesco Nasdaq Biotech UCITS ETF | -7.64% | 407.93M | Nov 2014 | CH5.L vs SBIO.L | |
| L&G Pharma Breakthrough UCITS ETF | -9.93% | 14.12M | Jan 2018 | CH5.L vs BIGT.L | |
| Lyxor UCITS MSCI World Health Care TR C-USD | -10.12% | 913.84M | Aug 2010 | CH5.L vs HLTW.L |
Other ETFs from Amundi
The 10 most viewed Amundi ETFs shown here include CSH2.L, MEUD.L, MWRD.L and span 6 categories. AUM among these funds goes as high as $17B.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|---|---|
| Lyxor Smart Overnight Return UCITS ETF C-GBP | Money Market | 99 | 1.74% | 16.89B | Mar 2015 | CH5.L vs CSH2.L | |
| Lyxor Core STOXX Europe 600 (DR) - UCITS ETF Acc | Europe Equities | 45 | 6.58% | 16.80B | Apr 2013 | CH5.L vs MEUD.L | |
| Amundi Index MSCI World | Global Equities | — | — | — | Nov 2016 | CH5.L vs MWRD.L | |
| Amundi FTSE 100 UCITS ETF | Europe Equities | 55 | 6.04% | 672.29M | Sep 2021 | CH5.L vs 100D.L | |
| Lyxor MSCI All Country World UCITS ETF | Global Equities | 87 | 12.22% | 2.05B | Nov 2018 | CH5.L vs ACWL.L | |
| Lyxor EURO STOXX Banks (DR) UCITS ETF - Acc | Financials Equities | 55 | 4.63% | 4.47B | Nov 2018 | CH5.L vs BNKE.L | |
| Amundi Nasdaq-100 UCITS USD | Nasdaq-100 | 76 | 19.66% | 3.58B | Apr 2018 | CH5.L vs ANXU.L | |
| Amundi Prime All Country World UCITS ETF Income | Global Equities | 86 | 11.92% | — | Jul 2025 | CH5.L vs PACW.L | |
| Amundi S&P 500 Swap UCITS ETF USD Acc | S&P 500 | 75 | 10.41% | 7.75B | Nov 2021 | CH5.L vs 500U.L | |
| Amundi MSCI World UCITS USD | Global Equities | 83 | 9.97% | 5.75B | Apr 2018 | CH5.L vs CW8G.L |
Often Compared With CH5.L
Investors most often compare CH5.L with LHTC.DE, EXV4.DE, WHCE.L. These 7 comparison targets span 2 categories, based on PortfoliosLab usage data.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|---|---|
| Lyxor STOXX Europe 600 Healthcare UCITS ETF Acc | Health & Biotech Equities | 14 | -2.55% | — | Aug 2006 | CH5.L vs LHTC.DE | |
| iShares STOXX Europe 600 Health Care UCITS ETF (DE... | Health & Biotech Equities | 13 | -2.60% | — | Apr 2001 | CH5.L vs EXV4.DE | |
| Invesco S&P World Health Care ESG UCITS ETF Acc | Health & Biotech Equities | 22 | -4.23% | — | Apr 2023 | CH5.L vs WHCE.L | |
| SPDR® MSCI Europe Health Care UCITS ETF | Health & Biotech Equities | 15 | -1.46% | 513.47M | Dec 2014 | CH5.L vs HLTH.L | |
| KraneShares MSCI All China Health Care Index UCITS... | Health & Biotech Equities | 6 | -10.68% | 1.50M | Jan 2021 | CH5.L vs KURE.L | |
| Amundi S&P 500 Swap UCITS ETF USD Acc | S&P 500 | 82 | 10.57% | — | Nov 2021 | CH5.L vs 500G.L | |
| iShares Healthcare Innovation UCITS ETF USD (Acc) | Health & Biotech Equities | 37 | 1.01% | 757.88M | Sep 2016 | CH5.L vs DRDR.L |
Compare CH5.L with Any Fund or Stock
Compare CH5.L with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.
Pair CH5.L with funds that move differently
Amundi ETF MSCI Europe Healthcare UCITS ETF alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to CH5.L.
Explore CH5.L Diversifiers